Abstract
Patients requiring extraction of infected or dysfunctional cardiac implantable electronic devices (CIED) have high morbidity and mortality. The Micra™ leadless cardiac pacemaker (LCP) may be beneficial for patients requiring permanent pacemaker therapy after CIED extraction. This study aimed to assess the feasibility, timing and outcomes of LCP implantation in patients who underwent CIED extraction due to infection or dysfunction. The local Micra™ LCP registry was reviewed for LCP implantations and CIED extractions. This study aimed to assess the feasibility, timing and outcomes of LCP implantation in patients who underwent CIED extraction due to infection or dysfunction. The local Micra™ LCP registry was reviewed for LCP implantations and CIED extractions.
| Original language | English |
|---|---|
| Pages (from-to) | 546-556 |
| Number of pages | 11 |
| Journal | Clinical Research in Cardiology |
| Volume | 115 |
| Issue number | 4 |
| Early online date | Aug 2024 |
| DOIs | |
| Publication status | Published - Apr 2026 |
Fields of science
- 302 Clinical Medicine
- 302032 Cardiology
- 305 Other Human Medicine, Health Sciences
- 303 Health Sciences
- 304 Medical Biotechnology
- 301 Medical-Theoretical Sciences, Pharmacy
- 302031 Intensive care medicine
- 302030 Internal medicine
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver